Local steroid therapy in cutaneous hemangiomas.
OBJECTIVE
To evaluate the efficacy of intralesional triamcinolone in enhancing regression in various type of hemangiomas.


METHODS
Outpatients department of a teaching hospital Subjects: One hundred and five patients with rapidly growing surface hemangioma. The age ranged from 1 month to 15 months (mean 7 months).


METHODS
Intralesional triamcinolone administered at monthly intervals, ranging from single injection to 7 injections (mean 3.6 injections).


METHODS
Regression of the hemangioma.


RESULTS
The overall response rate was 88.6% (excellent 51.4%, and good 37.2%). Maximum response was observed in children below 1 year of age (> 90%), lesions over the face (92.8%) and strawberry hemangiomas (99.9%).


CONCLUSIONS
Intralesional administration of triamcinolone devoid of systemic side effects and an effective initial modality for rapidly growing hermangiomas.
Gangopadhyay
A N
AN
Division of Pediatric Surgery and Plastic Surgery, Banaras Hindu University, Varanasi.
Sharma
S P
SP
Gopal
S C
SC
Gupta
D K
DK
Panjawani
K
K
Sinha
J K
JK
D005069:Evaluation Studies as Topic; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D015552:Injections, Intralesional; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D014221:Triamcinolone / Q000008:administration & dosage / Q000627:therapeutic use*
D005938:Glucocorticoids; D014221:Triamcinolone